Literature DB >> 7531346

Molecular mechanisms for B lymphocyte selection: induction and regulation of antigen-receptor-mediated apoptosis of mature B cells in normal mice and their defect in autoimmunity-prone mice.

T Tsubata1, M Murakami, S Nisitani, T Honjo.   

Abstract

Apoptosis (programmed cell death) has been suggested to be involved in clonal elimination of self-reactive lymphocytes for the normal function of the immune system. By crosslinking the antigen receptor (surface immunoglobulin; sIg) on the peritoneal B cells of normal mice, we found that strong crosslinking of sIg induces apoptosis of mature B cells, suggesting that interaction with membrane-bound self-antigens may eliminate self-reactive mature B cells by apoptosis. Antigen-receptor-mediated B cell apoptosis is blocked when a signal is transduced via the CD40 molecule on the B cell surface. Because the ligand of CD40 (CD40L) is expressed on activated T helper cells, B cells may escape from apoptosis and are activated when the immune system interacts with foreign antigens, which are normally able to activate T helper cells. Moreover, sIg crosslinking fails to induce apoptosis of both bcl-2-transgenic mice and autoimmune-disease-prone New Zealand mice. In these mice, the defect in sIg-mediated apoptosis of mature B cells may allow generation of self-reactive B cells, resulting in pathogenic consequences.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531346     DOI: 10.1098/rstb.1994.0109

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  2 in total

1.  Enhanced BCR signaling inflicts early plasmablast and germinal center B cell death.

Authors:  Juan Carlos Yam-Puc; Lingling Zhang; Raul A Maqueda-Alfaro; Laura Garcia-Ibanez; Yang Zhang; Jessica Davies; Yotis A Senis; Michael Snaith; Kai-Michael Toellner
Journal:  iScience       Date:  2021-01-07

2.  Effect of microRNA-181b on the biological characteristics and clinical drug resistance of small-cell lung cancer by targeting angiotensin converting enzyme 2.

Authors:  Guang Yang; Wenhao Wang; Shaohui Han; Siwei Xu; Huining Liu
Journal:  Thorac Cancer       Date:  2022-01-17       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.